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The use of hearing aids (HA) is considered a predisposing factor for ear mi-
crobial infections. We undertook this study to compare the presence and na-
ture of the microbial flora inhabiting of ears of HA and non-HA (nHA) users. 
Swab samples of the ears of HA and nHA users were collected from the In-
stitute of Otolaryngology, “Cattolica del Sacro Cuore” University “Agostino 
Gemelli”, Rome, Italy. Swab samples were taken from the ear canal of 57 HA 
and 33 nHA users. The components of the microbial flora present on each 
swab sample were identified and characterized at the level of species. A total 
of 41 different bacterial species were identified. A statistically significant pre-
valence of polymicrobial communities was found in ears presenting signs of 
inflammation (2.5 ± 1.7 vs 2.1 ± 1.3; P = 0.02) and in HA users (2.3 ± 1.2 vs 
1.7 ± 1.0; P = 0.002). Few putative pathogens were detected. Candida albicans 
spp. was not isolated in our study. A small number of swab samples presented 
no microbial growth. Bacterial species isolated from HA users with and 
without inflammation were assayed for the ability to form biofilm. Among 
gram-positive and gram-negative bacteria, S. aureus, CoNS, P. aeruginosa 
and K. pneumoniae were found to be strong biofilm producers. S. aureus and 
P. aeruginosa, isolated only from the ears of HA and nHA users presenting 
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signs of inflammation, were further analyzed for their antibiotic-resistance 
profile and characterized by the Multilocus Sequence Typing (MLST) assay. 
The highest rates of antibacterial resistance were in S. aureus to penicillin 
(75.5%) and in P. aeruginosa, to amoxicillin-clavulanic acid, cefotaxime, er-
tapenem, tigecycline and trimethoprim-sulfamethoxazole (100%). Moreover, 
three S. aureus strains (37.5%) were methicillin-resistant (MRSA). Of the 
eight S. aureus isolates, we identified six sequence types (ST) indicating that 
75% are likely independent clones. For what it concerned P. aeruginosa, six 
different STs were assigned. Interestingly, two out of the six strains presented 
newly identified ST values. This study sheds new light on the combined effect 
of the presence of HA devices and signs of external ear inflammation on the 
composition of the ear bacterial flora. Our results reinforce the need to prac-
tice careful hygiene of HA devices to prevent serious ear canal infections. 
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1. Introduction 
There are many causes of hearing loss [1]. Sensorineural presbycusis is the most 
common type of hearing loss, especially in elderly people, and hearing aids (HA) 
are the mainstay of treatment, that can improve patient quality of life. However, 
it is well known that the use of HAs could be a predisposing factor for the de-
velopment of bacterial infections that may lead to acute otitis externa (AOE) 
[1]-[7], a disease with a high incidence in the community population (approx-
imately 1% - 10%, with a peak in summer) [8]. Clinically, AOE consists of a mi-
crobial infection followed by severe inflammation of the external ear canal, often 
associated with ear pain, swelling, fluid accumulation, and rarely fever. Chronic, 
long-standing or recurrent middle ear infections often result in both conductive 
and sensorineural presbycusis. Bacteria and occasionally fungi (principally Sta-
phylococcus aureus, Pseudomonas aeruginosa, and Candida albicans) have 
been associated with the development of AOE. Nevertheless, also a variety of 
non-pathogenic microorganisms or local dermatologic processes have been im-
plicated in AOE development [9]. Among the auditory defenses, cerumen has 
been reported to contain substances that may counteract the action of microbial 
infections [10] [11].  
It has been previously reported that carriage of HA devices modifies the ear 
microbiota, favoring the proliferation of both commensal and pathogenic bacte-
ria, thus increasing the risk of AOE [3] [12] [13] [14]. Recently, AOE caused by 
highly antibiotic-resistant bacteria is an emerging concern for clinicians to era-
dicate these infections. Although there are several reports regarding the micro-
organisms involved in AOE, to date only a few studies are available on the cha-
racterization of the ear microbiological flora of healthy and patients with AOE 
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with or without HA [2] [15].  
This study is focused on the characterization of the microbial flora present in 
HA and non-HA (nHA) users with or without signs of inflammation. Moreover, 
biofilm production, allelic and antibiotic resistance profiles were also determined 
for some bacterial prototypes. 
2. Materials and Methods 
2.1. Study Subjects 
Fifty-seven hearing-impaired patients (39 men and 18 women) wearing hearing 
aids (HA) and 33 normal subjects (15 men and 18 women), ranging from 7 to 79 
years of age (mean 49.5 years), were enrolled in this study. Patients were informed 
about the purpose of the study and they gave a written informed consent. Ethical 
committee approval was obtained from the Ethical Committee of the University 
“Cattolica del Sacro Cuore”, Policlinico “A. Gemelli”, Rome, Italy (registration 
No. 20532/13). The otoscopic examination was carried out to detect signs of in-
flammation at the external auditory canal. Inflammation was defined mild when 
edema and occasionally clear secretions were present or moderate when edema, 
secretions, and debris of irritated skin were detected. Patients with active ear 
discharge, tympanic ear perforation, or that had taken any antimicrobial treat-
ment in the preceding seven days, were excluded from this study. Ear swab sam-
ples of the left ears (taken without cleaning of any debris/exudates or cerumen) 
of subjects with or without HA and with or without signs of inflammation were 
collected from February 2016 to September 2017. Samples were collected and 
placed in tubes containing sterile Amies transport culture medium with charcoal 
(Sterile transport swab, Oxoid) and transported to the Microbiology Laboratory 
for microbial isolation and characterization. HAs were removed just before sam-
pling. Samples were taken in spring to avoid seasonal colonization differences 
and to equalize the experimental conditions. 
2.2. Microbial Identifications 
Swabs were independently streaked onto a set of culture media plates, namely 
Blood agar, Chocolate agar supplemented or not with bacitracin, Mannitol Salt 
Agar, MacConkey 3 agar, Bile-esculin agar, Cetrimide, and Chromogenic Can-
dida agar plates (all from Oxoid). Plates were incubated for 24 - 48 hrs at 25 and 
37˚C in the presence or not of an atmosphere of 5% CO2. Sabouraud Dextrose 
agar plates were incubated up to seven days. A load of bacteria on the swabs was 
estimated by immersing the swabs in sterile tubes containing 1.0 ml of PBS for 1 
h to release microorganisms. Then, a volume of 0.1 ml of this solution was streaked 
on suitable culture plates and incubated at 37˚C for 48 hrs. The bacterial load 
was estimated as low (≤ 103 CFU∙ml−1), medium (103 - 104 CFU∙ml−1) and heavy 
(≥104 - 105 CFU∙ml−1). Isolates were identified at the level of species by conven-
tional microbiological methods (API® System and Vitek-2 Bio-Mèrieux) or by 
16S rDNA gene sequencing.  
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2.3. 16S rDNA Gene Sequencing 
The 16S rDNA gene sequencing was used to identify bacterial species that could 
not be identified by conventional biochemical methods. Briefly, total DNA was 
extracted by suspending three to five colonies in TE buffer (10 mM Tris, 1 mM 
EDTA, pH 7.8) and heating at 100˚C for 20 min. After centrifugation, superna-
tants were collected for PCR analysis. Universal primers  
8F (5’-AGAGTTTGATCCTGGCTCAG-3’) and  
1492R (5’-GGTTACCTTGTTACGACTT-3’) were used to amplify the 16S 
rDNA gene [16]. Amplicons were visualized by 1% agarose gel electrophoresis to 
confirm the presence of the expected 1500-bp fragment. Amplicons were quanti-
fied and sequenced bi-directionally using the same primers described above. 
Alignment and comparison of the 16S rDNA sequences were performed using 
the BLAST tool (https://pubmlst.org).  
2.4. Multilocus Sequence Typing 
Multilocus sequence typing (MLST) was used to determine genetic relatedness 
among of S. aureus and P. aeruginosa isolates. Species-specific primer pairs were 
used to amplify and sequence internal fragments of two sets of seven house-
keeping genes, as previously reported for S. aureus [17] and P. aeruginosa [18]. 
Total DNA extracts were prepared by using the GenElute Bacterial Genomic 
DNA system (Qiagen) according to the manufacturer’s instructions. Amplifica-
tion and sequencing were performed at the BMR Genomics, Padova, Italy by 
standard sequencing methods. 
Sequence types (ST) were determined by comparing the obtained sequences 
with the specific databases hosted at https://pubmlst.org. Only perfect matches 
were considered to assign amplified fragments to specific alleles.  
2.5. Antimicrobial Susceptibility Tests 
Antibiotic-resistance profiles of the eight S. aureus and of the six P. aeruginosa 
isolates was determined according to the guidelines of the European Committee 
on Antimicrobial Susceptibility Testing (EUCAST, version 6.0). Tests were per-
formed using the automated microbial system Vitek-2 (Bio-Mèrieux). The anti-
biotics used (Oxoid) are reported on the legends of Table 1 and Table 2. Mi-
nimal inhibitory concentrations (MICs) were also determined. 
2.6. Biofilm Assay 
The more prevalent bacteria species isolated from HA users with and without 
inflammation were assayed for the ability to form biofilm as previously de-
scribed [19] [20]. Escherichia coli strain 16 [19] and Staphylococcus epidermidis 
ATCC RP62A [20] were used as positive controls.  
Biofilms were quantified by measuring the absorbance at λ 595 nm (A595) with 
a microplate reader (Tecan Sunrise, X-fluor). A cut-off value of optical density 
(ODc), defined as the OD average of non-inoculated medium and a three  
M. Aleandri et al. 
 
 
DOI: 10.4236/***.2019.***** 5 Advances in Microbiology 
 
Table 1. Antibiotic resistance profiles of S. aureus strains. 
S. aureus isolates from: Strains penG met gen lvx ery cli lzd 
nHA users presenting 
signs of inflammation 
ORL 001 R (≥0.5) S (≤0.25) S (≤0.5) S (≤0.12) S (0.5) S (0.25) S (2) 
ORL 009 R (≥0.5) R (≥4) S (≤0.5) S (≤0.12) R (≥0.8) R (0.5) S (2) 
ORL 011 S (≤0.03) S (≤0.25) S (≤0.5) S (0.25) S (1) S (0.25) S (2) 
ORL 024 R (≥0.5) R (≥4) S (≤0.5) S (0.25) R (≥0.8) S (0.25) S (2) 
HA users presenting 
signs of inflammation  
ORL 028 R (≥0.5) R (≥4) R (≥16) S (≤0.12) S (1) S (0.25) S (2) 
ORL 094 R (≥0.5) S (≤0.25) S (≤0.5) S (≤0.12) S (1) S (0.25) S (2) 
ORL 099 R (≥0.5) S (0.5) S (≤0.5) S (0.25) S (1) S (0.25) S (2) 
ORL OC R (0.25) S (≤0.25) S (≤0.5) S (≤0.12) S (1) S (0.25) S (2) 
 
S. aureus isolates from: Strains dap tec van tet tgc fus rif sxt 
nHA users presenting 
signs of inflammation 
ORL 001 S (0.25) S (≤0.5) S (≤0.5) S (≤1) S (≤0.12) S (≤0.5) S (≤0.03) S (≤10) 
ORL 009 S (0.25) S (≤0.5) S (1) R (≥16) S (≤0.12) S (≤0.5) S (≤0.03) S (≤10) 
ORL 011 S (0.25) S (≤0.5) S (1) S (≤1) S (≤0.12) S (≤0.5) S (≤0.03) S (≤10) 
ORL 024 S (0.25) S (≤0.5) S (1) S (≤1) S (≤0.12) S (≤0.5) S (≤0.03) S (≤10) 
HA users presenting 
signs of inflammation 
ORL 028 S (0.25) S (≤0.5) S (1) S (≤1) S (≤0.12) S (≤0.5) S (≤0.03) S (≤10) 
ORL 094 S (0.25) S (≤0.5) S (1) R (≥16) S (≤0.12) S (≤0.5) S (≤0.03) S (≤10) 
ORL 099 S (0.5) S (≤0.5) S (1) S (≤1) S (≤0.12) S (≤0.5) S (≤0.03) S (≤10) 
ORL OC S (0.25) R (≥0.5) S (≤32) R (≥16) S (≤0.12) S (≤0.5) S (≤0.03) S (≤10) 
Antibiotic resistance profiles of the eight S. aureus strains isolated from the ears of HA and nHA users presenting signs of inflammation. Isolates were 
defined antibiotic susceptible (S) or resistant (R). Antibiotics used were: PenG: benzylpenicillin; met: methicillin; gen: gentamicin; lvx: levofloxacin; ery: 
erythromycin; cli: clindamycin; lzd: linezolid; dap: daptomycin; tec: teicoplanin; van: vancomycin; tet: tetracyclin; tgc: tigecycline; fus: fusidic; acid; rif: 
rifampicin; stx: trimethoprim-sulfamethoxazole. 
 
Table 2. Antibiotic resistance profiles of P. aeruginosa strains. 
P. aeruginosa isolates from: Strains amc tzp ctx caz cef etp imp 
nHA users presenting  
signs of inflammation 
ORL 001 R (≥32) S (8) R (16) S (2) S (0.5) R (≥8) S (2) 
ORL 006 R (≥32) S (≤4) R (16) S (2) S (8) R (≥8) S (2) 
ORL 011 R (≥32) S (8) R (16) S (2) S (≤1) R (≥8) S (1) 
ORL 016 R (≥32) S (8) R (≥64) S (4) S (2) R (≥8) S (0.5) 
ORL 025 R (≥32) S (8) R (32) S (4) S (2) R (4) S (1) 
HA users presenting  
signs of inflammation  ORL 074 R (≥32) S (≤4) R (16) S (2) S (≤1) R (≥0.8) S (2) 
 
P. aeruginosa isolates from: Strains mem amk gen cip tgc cst sxt 
nHA users presenting 
signs of inflammation 
ORL 001 S (1) S (≤2) S (≤1) S (≤0.25) R (≥8) S (≤0.5) R (80) 
ORL 006 S (≤0.25) S (4) S (4) S (≤0.25) R (≥8) S (≤0.5) R (160) 
ORL 011 S (≤0.25) S (≤2) S (≤1) S (≤0.25) R (≥8) S (≤0.5) R (80) 
ORL 016 S (≤0.25) S (≤2) S (≤1) S (≤0.25) R (≥8) S (≤0.5) R (160) 
ORL 025 S (≤0.25) S (≤2) S (≤1) S (≤0.25) R (≥8) S (≤0.5) R (≥320) 
HA users presenting 
signs of inflammation ORL 074 S (≤0.25) S (≤2) S (≤1) S (≤0.25) R (≥8) S (≤0.5) R (≥320) 
Antibiotic resistance profiles of the six P. aeruginosa strains isolated from the ears of HA and nHA users presenting signs of inflammation. Isolates were 
defined antibiotic susceptible (S) or resistant (R). Antibiotics used were: amc: amoxicillin-clavulanic acid; tzp: piperacillin-tazobactam; ctx: cefotaxime; caz: 
ceftazimide; cef: cefepime; etp: ertapenem; imp: imipenem; mem: meropenem; amk: amikacin; gen: gentamicin; cip: ciprofloxacin; tgc: tigecycline; cst: colis-
tin; sxt: trimethoprim-sulfamethoxazole. 
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standards deviation, was established. Strains were defined non-biofilm produc-
ers when the OD values were OD ≤ ODc; weak biofilm producers when OD val-
ues were ODc ≤ OD ≤ 2ODc; moderate biofilm producers when OD values were 
2ODc ≤ OD ≤ 4ODc and strong biofilm producers when OD values were OD ≥ 
4ODc [20]. 
2.7. Statistical Analysis 
The differences in the distribution of species and monomicrobial and polymicro-
bial communities among groups were calculated using the χ2 test (with Yates’ 
continuity correction). For species richness, a bilateral Mann-Whitney U-test was 
used to compare groups. In both cases, a P value ≤ 0.05 was considered statisti-
cally significant. 
3. Results 
3.1. Ears Sampling 
A total of 90 subjects were enrolled in this study. Swab samples were taken from 
left ears of 57 HA and 33 nHA users. Prior to sampling, the otoscope examina-
tion was used to detect signs of external auditory canal inflammation. Signs of 
mild/moderate inflammation were found in 22 subjects (10 out the 57 HA and 
12 out the 33 nHA users).  
3.2. Microbiological Characterization of Ear Samples 
A variety of microorganisms were recovered from swab cultures of the 90 sub-
jects and a total of 41 different bacterial species (29/41 Gram + and 12/41 Gram 
−) were identified. Bacteria considered part of the ear normal flora were the 
most common isolates. Among these, the majority were Coagulase-Negative 
Staphylococci (CoNS in Table 3), followed by Corynebacterium spp., Bacillus 
spp., and other microorganisms (Table 3). On the other hand, few putative pa-
thogenic microorganisms, namely S. aureus, S. agalactiae, E. coli, E. cloacae, K. 
pneumoniae and P. aeruginosa were isolated from 43 out of the 90 cultured 
swabs (47.7%). Putative pathogenic S. aureus and P. aeruginosa strains were iso-
lated only from HA and nHA users presenting signs of inflammation. No strains 
of Candida spp. were found. No microbial growth was observed with a statisti-
cally significant prevalence among nHA compared to HA users (6 out of 33 vs 1 
out of 57, respectively; P = 0.032).  
Moreover, the statistically significant prevalence of the bacterial species in 
with respect to the different groups of patients was evaluated. In this analysis, we 
found that the predominant microorganism recovered was CoNS found in the 
great majority of samples (91.1%, 82/90), independently from the presence of 
signs of inflammation (respectively, 22/22 patients with inflammation vs 60/68 
patients without signs of inflammation, P < 0.001) (Table 3). Moreover, Cory-
nebacterium spp. and Micrococcus spp. were statistically prevalent in ears pre-
senting signs of inflammation (respectively, 4/22 vs 1/68, P < 0.012 and 4/22 vs  
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presenting signs of 
inflammation (n. 10) 
HA users without 
any signs of 
inflammation (n. 47) 
nHA users 
presenting signs of 
inflammation (n. 12) 
nHA users without 
any signs of 
inflammation (n. 21) 
Gram-positive     
Corynebacterium spp. 2/10 20% 1 2.1% 2 16.7% - - 
Brevibacterium sanguinis - - - - 1 8.3% - - 
Kocuria varians/rosea - - - - 1 8.3% - - 
Micrococcus spp. 2/10 20% - - 2 16.7% 2 9.5% 
Bacillus spp. 1/10 10% 19 40.4% - - - - 
Gemella haemolysans - - 1 2.1% - - - - 
Staphylococcus aureus 4/10 40%   4 33.3% -  
CoNS 10/10 100% 42 89.4% 12 100% 18 85.7% 
Streptococccus agalactiae - - - - 1 8.3% - - 
Enterococcus faecalis - - - - 1 8.3% - - 
Aerococcus viridans 1/10 10% - - - - - - 
Gram-negative     
Citrobacter freundii 2/10 20% - - - - - - 
Escherichia coli 1/10 10% 6 12.8% - - - - 
Enterobacter cloacae 4/10 40% 9 19.1% - - - - 
Enterobacter ludwigii. 1/10 10% - - - - - - 
Klebsiella pneumoniae 1/10 10% 6 12.7% - - - - 
Klebsiella variicola. 1/10 10% - - - - - - 
Pantoea agglomerans - - 1 2.1% -  - - 
Pseudomonas aeruginosa 1/10 10% - - 5 41.7% - - 
Pseudomonas luteola - - 2 4.3% - - - - 
Achromobacter spp. - - 1 2.1% - - - - 
Ralstonia pickettii 1/10 10% - - -  - - 
Microbiological analysis of bacterial flora colonizing the ear canal of HA and nHA users presenting or not inflammation. Isolates were identified at the level 
of species by conventional microbiological methods and 16S rDNA sequencing. The number of bacterial species and the percentage of isolates are indicated. 
Corynebacterium spp. were C. afermentas, C. aurimucosum, C. pseudodiftericum, and Corynebacterium of unknown species. Bacillus spp. were B. subtilis, 
B. amyloliquefaciens, B. licheniformis, B. mojavensis, B. pseudomycoides, B. pumilus, B. simplex and Bacillus of unknown species. CoNS were S. auricularis, 
S. capitis, S. epidermidis, S. haemolyticus, S. hominis, S. sciuri, S. warneri, S. warneri/pasteuri and S. xylosus. 
 
2/68; P < 0.03). On the other hand, Bacillus spp. was statistically prevalent among 
HA users (20/57 vs 0/33; P < 0.019) (Table 3). For what it regards putative pa-
thogenic strains, E. cloacae was isolated only among HA users (13/57 vs 0/33; P 
= 0.02) while P. aeruginosa (six isolates) and S. aureus (eight isolates) were ex-
clusively recovered from ears presenting signs of inflammation (respectively, 
6/22 vs 0/68; P < 0.0001 and 8/22 vs 0/68; P < 0.0001). 
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Polybacterial flora, mainly composed of commensals, was recovered with a 
statistically significant prevalence among nHA respect to HA users (27/33 vs 
40/57, P < 0.049). A deeper evaluation of the complexity of these bacterial com-
munities was conducted by determining species richness and the average num-
ber of bacterial species recovered per swab sample. To this end, the number of 
bacterial species recovered from HA and nHA users, with or without signs of in-
flammation, were compared and polymicrobial communities were statistically 
prevalent in subjects with signs of inflammation respect to subject without in-
flammations (2.5 ± 1.7 vs 2.1 ± 1.3; P = 0.02). Consequently, polymicrobial 
communities were confirmed to be statistically prevalent in nHA in with respect 
to HA users (2.3 ± 1.2 vs 1.7 ± 1.0; P = 0.002). Taken together these results indi-
cate that the presence of HA as well as of inflammation are conditions that may 
favor the formation of polybacterial communities within the external ear canal.  
3.3. Antibiotic-Resistance Profiles of S. aureus and P. aeruginosa  
Strains Isolated from HA and nHA Users Presenting Signs of  
Inflammation 
Since S. aureus and P. aeruginosa were recovered only from HA and of nHA us-
ers presenting signs of inflammation (Table 3), we decided to better characterize 
these strains. To this end, we first determined their antibiotic-resistance profiles 
(Table 1 and Table 2). All strains of S. aureus were sensitive (S) to a variety of 
antibiotics, namely linezolid, daptomycin, vancomycin, tigecycline, fusidic acid, 
rifampicin and trimethoprim-sulfamethoxazole. Almost all strains were resistant 
(R) to penicillin G, three strains were methicillin-resistant (MRSA), and pre-
sented different antibiotic resistance profiles (Table 1). For what it concerned P. 
aeruginosa, the strains showed very similar antibiotic-resistance profiles (they 
were 100% resistant to amoxicillin-clavulanic acid, cefotaxime, ertapenem, tige-
cycline and trimethoprim-sulfamethoxazole) (Table 2).  
3.4. Allelic Variation in S. aureus and P. aeruginosa  
To determine genetic relatedness among the S. aureus and P. aeruginosa strains, 
an MLST typing assay was performed, as described in Materials and Methods. 
The specific housekeeping genes and the primers used to amplify internal DNA 
fragments of S. aureus and P. aeruginosa were previously described [17] [18] 
(Table 4 and Table 5). The PCR amplicons obtained were sequenced and se-
quences were assigned as distinct alleles by comparison with available specific 
MLST database. Subsequently, the sequence type (ST) values, for each isolate, 
were determined basing on its allelic profile. Table 4 and Table 5 show the dif-
ferent allelic profiles for each S. aureus and P. aeruginosa isolates. Of the eight S. 
aureus isolates, we identified six STs indicating that 75% are likely independent 
clones. In fact, two strains were assigned to ST8 and two to ST15 (Table 4) indi-
cating that they represent genetically related clones. For what it concerned P. 
aeruginosa, the results obtained clearly indicated that they were unrelated to 
each other (six different ST values were assigned). Interestingly, two out of the  
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arcC aroE glpF gmk Pta tpi yqiL 
ORL001 7 6 1 70 8 8 6 737 − 
ORL009 1 1 1 1 1 1 1 1 − 
ORL011 5 4 1 4 4 6 3 7 − 
ORL024 3 3 1 1 4 4 3 8 − 
ORL028 3 3 1 1 4 4 3 8 + 
ORL094 2 2 2 2 15 3 2 37 + 
ORL099 13 13 1 1 12 11 13 15 + 
ORLOC 13 13 1 1 12 11 13 15 + 
Allelic variations of S. aureus strains isolated from the ears. Multilocus Sequence Typing (MLST) assays 
were conducted. ST: sequence type; HA−: strains isolated from nHA users; HA+: strains isolated from HA 
users. 
 




acsA aroE guaA mutL nuoD ppsA trpE 
ORL00l 67 5 12 3 14 4 7 new + 
ORL006 6 5 6 7 4 6 7 27 − 
ORL011 13 75 5 5 12 7 15 481 − 
ORL016 9 87 5 5 1 6 47 new − 
ORL025 27 91 5 3 1 6 64 522 − 
ORL074 6 5 6 3 74 13 7 672 − 
Allelic variations of P. aeruginosa strains isolated from the ears. Multilocus Sequence Typing (MLST) assays 
were conducted. ST: sequence type; HA−: strains isolated from nHA users; HA+: strains isolated from HA 
users. 
 
six strains presented newly identified ST values (Table 5). These results indi-
cated that the P. aeruginosa isolates are likely independent clones, thus con-
firming previous reports indicating the high genetic variability of this facultative 
pathogen [18].  
3.5. Biofilm Production 
The ability to produce biofilm was evaluated, as described in Materials and Me-
thods, for all different bacterial species isolated from HA users, with or without 
signs of inflammation. In general, biofilm production was found to be statisti-
cally not correlated to the presence of signs of inflammation. Gram-positive 
bacteria, such as S. aureus and CoNS, were found to be strong biofilm producers. 
Among Gram-negative putative bacterial pathogens, all strains of P. aeruginosa, 
K. pneumoniae, were strong biofilm producers, while E. coli and E. cloacae ap-
peared weak/moderate biofilm producers (data not shown). Taken together our 
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results indicated that biofilm production appears to be a quite diffuse property 
among bacterial species colonizing the ear canal of HA users, independently 
from inflammation. This may contribute to the development of infection to the 
external ear canal and likely to the progression to acute otitis externa (AOE). 
4. Discussions 
One relevant characteristic of the external auditory canal is its unique cul-de-sac 
anatomical structure that readily traps moisture thereby favoring colonization 
and growth of a wide range of microorganisms (either commensal or patho-
gens). Moisture retention, caused by the presence of hearing aids (HA), may fa-
vor occlusion of the ear canal and thus bacterial colonization also of the HA de-
vice by biofilm-producing microorganisms. Thus, HA carriage, especially if it is 
not followed by daily efficient cleaning and disinfection of the HA device, is 
considered a risk factor for the development of external canal infections [2] [15]. 
In this work, we found that the presence of polybacterial communities, mainly 
constituted by commensals, is a quite diffuse characteristic of the ear canals of 
HA wearers. Thus, under particular situations, these polybacterial communities, 
either by exerting a synergistic effect on other microorganisms or by biofilm 
production, might concur to the development of acute otitis externa (AOE). 
Accordingly, it has been recently reported that pediatric, geriatric or im-
mune-compromised patients are subjects at risk to develop AOE as well as sys-
temic infections driven by microorganisms considered innocuous [21]. In this 
contest, it is worth to recall that biofilm production may constitute a scaffold for 
colonization of non-biofilm producing microorganisms, including pathogens, 
and thus this feature is considered an important virulence factor that allows mi-
croorganisms to better resist to the host immune response and to the antibiotic 
therapy [22].  
This study is aimed at identifying and at comparing the microbial flora present 
in the ear canal of 57 HA and of 33 nHA users. Of these, 10 out of the 57 HA 
and 12 out of the 33 nHA users, presented signs of external auditory canal in-
flammation (mild/moderate). During microbial identification, we noticed sig-
nificant differences in the distribution of bacterial species among the microbial 
flora of HA and nHA users (Table 3). Moreover, significant differences were al-
so found for what it concerned the number of bacterial species isolated. A sig-
nificantly higher number of microorganisms arose from swab samples of HA 
(about 104 - 105 CFU/ml) compared to nHA users (about 102 - 103 CFU/ml), in-
dicating that carriage of HA devices per se may favors bacterial colonization of 
the ear canal. Although CoNS (Staphylococcus spp. in Table 3) strains are 
usually considered to be non-pathogenic, CoNSs were the commonest isolated 
organism (91.1%) among HA or and of nHA users, presenting or not signs of in-
flammation. CoNS were isolated alone or in combination with other microor-
ganisms (Table 3). Different forms of putative pathogenic bacteria (see Result 
section) were also isolated (Table 3). Interestingly, eight S. aureus and six P. ae-
ruginosa strains were recovered only from HA and nHA users presenting signs 
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of inflammation (respectively, 4/10 and 4/12; and 1/10 and 5/12). Although the 
number of subjects examined in this study is small, these results seem to indicate 
that inflammation may favor ear colonization by these pathogens that have been 
reported to be involved in the development of AOE [23]. Biofilm formation is 
considered an important virulence factor which allows bacteria to bind and to 
multiply within host tissues as well as to abiotic substrates (like the surfaces of 
HA devices) [24]. To ascertain whether bacterial species colonizing the ear canal 
of HA users were able to produce biofilm, we assayed representative bacterial 
species found on the ear canal of HA users with or without signs of inflamma-
tion. The results obtained indicated that biofilm production is a quite diffuse 
phenomenon among bacteria inhabiting the ear canal of HA users independent-
ly from inflammation. Interestingly, CoNS strains were also found to be strong 
biofilm producers. Since CoNS was the predominant microorganism recovered 
(see above) (Table 3), it is possible to envisage that the presence in the ear canal 
of these biofilm producers might influence the composition of the bacterial 
community in HA users and could provide optimal conditions for bacterial 
growth and antibiotic resistance.  
Although the majority of isolates were components of the common normal 
flora of the ear, few putative pathogens were also recovered. Among these strains, 
S. aureus and P. aeruginosa were found to be strong biofilm producers.  
Moreover, to further characterize S. aureus and P. aeruginosa strains, antibi-
otic-susceptibility and genetic relatedness (using an MLST scheme) were eva-
luated. For what it concerned antibiotic-resistance, the results obtained con-
firmed that the P. aeruginosa, compared to S. aureus presented a broader spec-
trum of antibiotic-resistance [25].  
Nowadays the analysis of allelic variations of microorganisms is considered an 
important molecular tool (MLST test) used to precisely identify genetic related-
ness among bacterial strains in order to study the insurgence and spread of spe-
cific microbial pathogens as well as of their epidemiology. A MLST assay was 
used to evaluate the genetic relatedness among isolates of S. aureus and of P. ae-
ruginosa [17] [18]. PCR amplicons were generated and their sequences assigned 
to distinct alleles in order to determine sequence type (ST; see Materials and 
Methods for details). The six isolates of P. aeruginosa presented different ST 
values indicating that they are epidemiologically unrelated clones (Table 4), 
while S. aureus strains presented a lower level of genetic variability (Table 5). 
These results are in agreement with previous reports indicating high genetic va-
riability for P. aeruginosa [18]. 
5. Conclusion 
In conclusion, although the great majority of bacteria isolated in this study be-
longed to the common normal ear flora, some putative pathogens were also 
identified. For this reason, we would like to stress the need for HA users to 
carefully clean and disinfect their HA devices at least daily, in order to minimize 
the risk of developing serious ear canal infections. 
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